There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Survivin is a negative regulator of apoptosis. We evaluated the efficacy of YM155,
a selective suppressant of survivin, in combination with gemcitabine in the pancreatic
cancer cell line MiaPaCa-2.